Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Preferred Stock Liabilities: 2015

  • Editas Medicine's Preferred Stock Liabilities was N/A to $119.8 million in Q4 2015 from the same period last year, while for Dec 2015 it was $119.8 million, marking a year-over-year change of. This contributed to the annual value of $119.8 million for FY2015, which is N/A change from last year.
  • As of Q4 2015, Editas Medicine's Preferred Stock Liabilities stood at $119.8 million.
  • Editas Medicine's 5-year Preferred Stock Liabilities high stood at $119.8 million for Q4 2015, and its period low was $119.8 million during Q4 2015.
  • In the last 1 years, Editas Medicine's Preferred Stock Liabilities had a median value of $119.8 million in 2015 and averaged $119.8 million.